biotech · Systemic Lupus Erythematosus · Primary Progressive Multiple Sclerosis (PPMS) · ZBIO
Zenas BioPharma
Zenas BioPharma clinical programs — 13 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 1000 Winter St, Suite 1200, Waltham, MA 02451, US
- Employees
- 176
- Programs
- 13
- Drugs
- 10
- Patents
- 0
Zenas BioPharma projects
13 ClinicalTrials.gov programs sponsored by Zenas BioPharma.
Zenas BioPharma has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Obexelimab
Zenas BioPharma
IgG4 Related Disease
1 trial -
Obexelimab
Zenas BioPharma
Warm Autoimmune Hemolytic Anemia
1 trial -
Orelabrutinib
Zenas BioPharma
Multiple Sclerosis (MS) Primary Progressive
1 trial -
Orelabrutinib
Zenas BioPharma
Secondary Progressive Multiple Sclerosis
1 trial -
ZB020-03-001
Zenas BioPharma
Primary Progressive Multiple Sclerosis (PPMS)
1 trial -
Obexelimab
Zenas BioPharma
Systemic Lupus Erythematosus
1 trial -
Obexelimab
Zenas BioPharma
Relapsing Multiple Sclerosis
1 trial -
ZB012-02-001
Zenas BioPharma
Systemic Lupus Erythematosus
1 trial -
ZB012-02-002
Zenas BioPharma
RELAPSING MULTIPLE SCLEROSIS
1 trial -
ZB001 for injection
Zenas BioPharma
Thyroid Eye Disease
1 trial -
ZB001 for injection
Zenas BioPharma
Healthy Volunteers
1 trial -
ZB002
Zenas BioPharma
Healthy Volunteers
1 trial -
ZB004
Zenas BioPharma
Healthy Volunteers
1 trial
Frequently asked questions
How many clinical projects does Zenas BioPharma have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.